114 related articles for article (PubMed ID: 10066372)
1. Identification of a 220-kDa membrane tumor-associated antigen by human anti-UK114 monoclonal antibodies selected from the immunoglobulin repertoire of a cancer patient.
Funaro A; Horenstein AL; Ghisolfi G; Bussolati B; Bartorelli A; Bussolati G
Exp Cell Res; 1999 Mar; 247(2):441-50. PubMed ID: 10066372
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
[TBL] [Abstract][Full Text] [Related]
3. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
4. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
[TBL] [Abstract][Full Text] [Related]
5. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
8. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
10. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to human osteosarcoma-associated antigen(s).
Tsang KY; Warren RQ; Bishop L; Pathak S; Koger B; LaVia MF
J Natl Cancer Inst; 1986 Dec; 77(6):1175-80. PubMed ID: 3467110
[TBL] [Abstract][Full Text] [Related]
12. Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies.
Tinari N; D'Egidio M; Iacobelli S; Bowen M; Starling G; Seachord C; Darveau R; Aruffo A
Biochem Biophys Res Commun; 1997 Mar; 232(2):367-72. PubMed ID: 9125183
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
15. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
16. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies against surface antigens of cancer cells. Experimental preparation for early diagnosis and immuno-assisted therapy].
Zenner HP
Fortschr Med; 1983 May; 101(19):891-2, 894. PubMed ID: 6873841
[TBL] [Abstract][Full Text] [Related]
18. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
Brown JM
Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
[TBL] [Abstract][Full Text] [Related]
19. The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4.
Shoji M; Kawamoto S; Setoguchi Y; Mochizuki K; Honjoh T; Kato M; Hashizume S; Hanagiri T; Yoshimatsu T; Nakanishi K
Hum Antibodies Hybridomas; 1994; 5(3-4):123-30. PubMed ID: 7756577
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies to neuroendocrine granules derived from tumor-infiltrating lymphocytes isolated from a primitive neuroectodermal tumor.
Banerjee D; Karim R; Hearn SA; Geddes D
Hum Antibodies Hybridomas; 1990; 1(1):55-63. PubMed ID: 1966474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
